lobbying_activities: 4026696
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4026696 | 15281d24-137d-4afb-a536-c6d69c9f8667 | Q2 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2026 | second_quarter | MED | FY 2027 appropriations for the development of a synthetic vaccine | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T10:35:39-04:00 |